Sara Colomer-Lahiguera

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


41 publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
 
La pratique infirmière avancée : une réponse aux défis du système de santé.
Gentizon J., Colomer-Lahiguera S., Mabire C., Eicher M., Robatto L., Peguet C., 2024/12/11. Revue medicale suisse, 20 (898-2) pp. 2323-2324. Peer-reviewed.
Role, education, policies and competencies for advanced practice in paediatric haematology-oncology nursing in Europe: A scoping review.
Amicucci M., Trigoso E., Nori M., Colomer-Lahiguera S., Rostagno E., Biagioli V., Sansone V., Zibaldo A., Mastria A., Partel M.C. et al., 2024/12. Pediatric blood & cancer, 71 (12) pp. e31325. Peer-reviewed.
 
Worse Psychological Profiles Are Associated With Higher Levels of Stress and Symptom Burden in Patients With Cancer During the COVID-19 Pandemic.
Colomer-Lahiguera S., Pozzar R.A., Cooper B.A., Paul S.M., Snowberg K., Kenfield S.A., Chang S.M., Abbott M., Van Blarigan E.L., Levine J.D. et al., 2024/10/17. Oncology nursing forum, 51 (6) pp. 529-546. Peer-reviewed.
Reflections on the opportunities and challenges of applying experience-based co-design (EBCD) to phase 1 clinical trials in oncology.
Graber N., Canova N., Bryant-Lukosius D., Robert G., Navarro-Rodrigo B., Trueb L., Coukos G., Eicher M., Corbière T., Colomer-Lahiguera S., 2024/08. Health expectations, 27 (4) pp. e14068. Peer-reviewed.
Achieving Comprehensive, Patient-Centered Cancer Services: Optimizing the Role of Advanced Practice Nurses at the Core of Precision Health.
Colomer-Lahiguera S., Gentizon J., Christofis M., Darnac C., Serena A., Eicher M., 2024/06. Seminars in oncology nursing, 40 (3) p. 151629. Peer-reviewed.
Patient-Reported Experiences of Supportive Cancer Care during the COVID-19 Pandemic
Canella Claudia, Naegele Matthias, Ribi Karin, Colomer-Lahiguera Sara, Giacomini Stellio, Van Kim Lê, Eicher Manuela, Witt Claudia M., 2024/05/18. European Journal of Cancer Care, 2024 pp. 1-8. Peer-reviewed.
Testing a Model of Care for Patients on Immune Checkpoint Inhibitors Based on Electronic Patient-Reported Outcomes: Protocol for a Randomized Phase II Controlled Trial.
da Silva Lopes A.M., Colomer-Lahiguera S., Darnac C., Giacomini S., Bugeia S., Gutknecht G., Spurrier-Bernard G., Cuendet M., Muet F., Aedo-Lopez V. et al., 2023/10/18. JMIR research protocols, 12 pp. e48386. Peer-reviewed.
Development of an eHealth-enhanced model of care for the monitoring and management of immune-related adverse events in patients treated with immune checkpoint inhibitors.
da Silva Lopes A.M., Colomer-Lahiguera S., Darnac C., Giacomini S., Bugeia S., Gutknecht G., Spurrier-Bernard G., Aedo-Lopez V., Mederos N., Latifyan S. et al., 2023/07/22. Supportive care in cancer, 31 (8) p. 484. Peer-reviewed.
Patient and public involvement in cancer research: A scoping review.
Colomer-Lahiguera S., Steimer M., Ellis U., Eicher M., Tompson M., Corbière T., Haase K.R., 2023/07. Cancer medicine, 12 (14) pp. 15530-15543. Peer-reviewed.
Patient-reported experiences of cancer care related to the COVID-19 pandemic in Switzerland.
Colomer-Lahiguera S., Canella C., Giacomini S., Van K.L., Pedrazzani C., Naegele M., Thouvenin L., O'Meara Stern A., Condorelli R., Corbière T. et al., 2023/06/22. Supportive care in cancer, 31 (7) p. 410. Peer-reviewed.
Big Data in Oncology Nursing Research: State of the Science.
Harris C.S., Pozzar R.A., Conley Y., Eicher M., Hammer M.J., Kober K.M., Miaskowski C., Colomer-Lahiguera S., 2023/06. Seminars in oncology nursing, 39 (3) p. 151428. Peer-reviewed.
Patient and public involvement in research: Reflections and experiences of doctoral cancer nurse researchers in Europe.
Tanay M.A., Diez de Los Rios de la Serna C., Boland V., Lopes AMDS, Wingfield K., Chircop D., Dornan M., Suchodolska G., Yıldız Aytaç G., Kurt B. et al., 2023/06. European journal of oncology nursing, 64 p. 102351. Peer-reviewed.
An Overview of the Fundamentals of Data Management, Analysis, and Interpretation in Quantitative Research.
Kotronoulas G., Miguel S., Dowling M., Fernández-Ortega P., Colomer-Lahiguera S., Bağçivan G., Pape E., Drury A., Semple C., Dieperink K.B. et al., 2023/04. Seminars in oncology nursing, 39 (2) p. 151398. Peer-reviewed.
Cancer nursing research priorities: A rapid review.
Dowling M., Efstathiou N., Drury A., Semple C., Fernández-Ortega P., Brochstedt Dieperink K., Pape E., Kotronoulas G., Miguel S., Colomer-Lahiguera S. et al., 2023/04. European journal of oncology nursing, 63 p. 102272. Peer-reviewed.
Patient-reported outcomes in adoptive cell-therapy trials: mind the gap.
Ghisoni E., Morotti M., Colomer-Lahiguera S., Eicher M., Coukos G., Trueb L., Di Maio M., 2022/12. Journal for immunotherapy of cancer, 10 (12) pp. e006082. Peer-reviewed.
Patients' experiences with cancer care in Switzerland: Results of a multicentre cross-sectional survey.
Arditi C., Eicher M., Colomer-Lahiguera S., Bienvenu C., Anchisi S., Betticher D., Dietrich P.Y., Duchosal M., Peters S., Peytremann-Bridevaux I., 2022/11. European journal of cancer care, 31 (6) pp. e13705. Peer-reviewed.
 
CN37 Patient and public involvement in research: Reflections and experiences of doctoral cancer nurse researchers in Europe
Tanay M.A., Díez de los Ríos de la Serna C., Boland V., Lopes A.M.D.S., Dornan M., Wingfield K., Yildiz G., Chircop D., Suchodolska G., Kurt B. et al., 2022/09., Annual Meeting of the European-Society-for-Medical-Oncology (ESMO) pp. S1364 dans Annals of Oncology.
 
CN39 Development of a reference model for patient and public involvement in oncology research in French-speaking Switzerland
Colomer-Lahiguera S., Corbière T., Soukup K., Reeb-Landry F., Addeo A., Eicher M., 2022/09., Annual Meeting of the European-Society-for-Medical-Oncology (ESMO) pp. S1365 dans Annals of Oncology.
 
CN66 Evolution of quality of life and symptoms in patients with lung cancer or melanoma during the first months of immune checkpoint blockade treatment
Colomer-Lahiguera S., Guerra da Souza A.C., Darnac C., Soukup K., Marcone R., Eicher M., 2022/09., Annual Meeting of the European-Society-for-Medical-Oncology (ESMO) pp. S1373-S1374 dans Annals of Oncology.
 
Qualité de vie et immunothérapie : un examen plus approfondi s’impose
Colomer-Lahiguera Sara, 2022/08/20. Journal professionnel de Soins en Oncologie Suisse.
Implication des patients dans la recherche en oncologie - Développement d’un cadre de référence en Suisse romande [Patient involvement in oncology research - Development of a reference framework in French-speaking Switzerland]
Colomer-Lahiguera S., Corbière T., Reeb-Landry F., Ninane F., Addeo A., Eicher M., 2022/03/30. Revue medicale suisse, 18 (775) pp. 621-625. Peer-reviewed.
Nurse-Led Consultation and Symptom Burden in Patients with Head and Neck Cancer: A Comparative Analysis of Routine Clinical Data.
Luta X., Colomer-Lahiguera S., Martins Cardoso R.J., Hof F., Savoie M., Schuler C., Wicht J., Fucina N., Debarge P., Ninane F. et al., 2022/02/26. Cancers, 14 (5) p. 1227. Peer-reviewed.
Patient-reported outcomes for monitoring symptomatic toxicities in cancer patients treated with immune-checkpoint inhibitors: A Delphi study.
Da Silva Lopes A.M., Colomer-Lahiguera S., Mederos Alfonso N., Aedo-Lopez V., Spurrier-Bernard G., Tolstrup L.K., Pappot H., Aspeslagh S., Rogiers A., Neyns B. et al., 2021/11. European journal of cancer, 157 pp. 225-237. Peer-reviewed.
 
1686P Selecting patient-reported outcomes to monitor symptomatic toxicities of immune-checkpoint inhibitors: A Delphi study
Lopes A.M.D.S., Colomer-Lahiguera S., Mederos-Alfonso N-N., Lopez V. Aedo, Spurrier-Bernard G., Tolstrup L.K., Pappot H., Aspeslagh S., Rogiers A., Neyns B. et al., 2021/09., ESMO Congress 2021 pp. S1180 dans Annals of Oncology.
Experiences of people affected by cancer during the outbreak of the COVID-19 pandemic: an exploratory qualitative analysis of public online forums.
Colomer-Lahiguera S., Ribi K., Dunnack H.J., Cooley M.E., Hammer M.J., Miaskowski C., Eicher M., 2021/09. Supportive care in cancer, 29 (9) pp. 4979-4985. Peer-reviewed.
Six étudiantes en temps de pandémie: Témoignages illustrés d'infirmières en formation master et doctorat durant la période COVID-19
Colomer-Lahiguera Sara, Masserey Cléa, 2021/07/01..
Suivi téléphonique des patients testés positifs au SARS-CoV-2 au Département d’oncologie du CHUV [Telephone follow-up of SARS-CoV-2 positive patients at the Oncology Department of Lausanne University Hospital]
Jankovic J., Da Silva Lopes A.M., Morez A., Darnac C., Demicheli R., Dalla-Vale M., Lauriers N., Garcia Sanchez J., Bouchaab H., Ninane F. et al., 2021/04/07. Revue medicale suisse, 17 (733) pp. 703-707. Peer-reviewed.
Cancer Care of Children, Adolescents and Adults With Autism Spectrum Disorders: Key Information and Strategies for Oncology Teams
Vuattoux Delphine, Colomer-Lahiguera Sara, Fernandez Pierre-Alain, Jequier Gygax Marine, Choucair Marie-Louise, Beck-Popovic Maja, Diezi Manuel, Manificat Sabine, Latifyan Sofiya, Ramelet Anne-Sylvie et al., 2021/01/19. Frontiers in Oncology, 10.
 
Development and Implementation of Patient-Reported Outcome Measures in Cancer Care
Da Silva Lopes André Manuel, Colomer-Lahiguera Sara, Eicher Manuela, 2021/01/06. dans Developing and Utilizing Digital Technology in Healthcare for Assessment and Monitoring, Springer.
 
CN26 Patient-reported experiences of cancer care related to the COVID-19 pandemic in Switzerland: A qualitative study
Colomer-Lahiguera S., Ribi K., Witt C.M., Eicher M., 2020/09. pp. S1137 dans Annals of Oncology.
 
CN31 Oncology nurses' experience in German and French-speaking Switzerland during the COVID-19 pandemic
Eicher M., Bana M., Darnac C., Hellberg M.N., Colomer-Lahiguera S., 2020/09., ESMO Virtual Congress 2020 19 – 21 September / 16 – 18 October 2020 pp. S1138 dans Annals of Oncology, Elsevier BV.
Patient-reported outcome instruments used in immune-checkpoint inhibitor clinical trials in oncology: a systematic review.
Colomer-Lahiguera S., Bryant-Lukosius D., Rietkoetter S., Martelli L., Ribi K., Fitzpatrick-Lewis D., Sherifali D., Orcurto A., Juergens R., Eicher M., 2020/07/16. Journal of patient-reported outcomes, 4 (1) p. 58. Peer-reviewed.
 
Describing adverse events in Swiss hospitalized oncology patients using the Global Trigger Tool.
Gerber A., Da Silva Lopes A., Szüts N., Simon M., Ribordy-Baudat V., Ebneter A., Perrinjaquet C., Gaignard M.E., Nicodet D., Betticher D. et al., 2020/06. Health science reports, 3 (2) pp. e160. Peer-reviewed.
 
Le fardeau lié aux symptômes et les symptom clusters des patient·e·s atteint·e·s de cancer ORL et traité·e·s en radiothérapie. Onkologiepflege, 32-36, Nr. 2-2020 (2020).
Schuler Cosette, Hof Frank, Cardoso Rodrigo, Debarge Patricia, Manciana Stefania, Ninane Françoise, Bourhis Jean, Eicher Manuela, 2020/01..
 
Médecine personnalisée. Bases de la formation interprofessionnelle prégraduée, postgraduée et continue des professionnels de la santé.
Colomer-Lahiguera Sara, 2019/07/08. dans Chapitre 10. La médecine personnalisée en oncologie, Académie Suisse des Sciences Médicales.
 
Les patients ont une voix : Les résultats de santé rapportés par les patients sous immunothérapie. Onkologiepflege, Nr. 3-2019 (2019).
Colomer-Lahiguera Sara, Darnac Célia, Da Silva Lopes André, Ninane Françoise, Eicher Manuela, 2019..
 
CN29: The use of patient reported outcome (PRO) instruments in immune checkpoint inhibitor (ICI) therapy for cancer: A systematic review
Colomer-Lahiguera S., Bryant-Lukosius D., Rietkoetter S., Martelli L., Ribi K., Orcurto A., Juergens R., Eicher M., 2018/10., 43rd ESMO Congress (ESMO) pp. viii690 dans Annals of Oncology.
 
Adoptive zelluläre Immuntherapie in der Schweiz. Onkologische Pflege 2 (2018).
Colomer-Lahiguera Sara, Debarge Patricia, Serena Andrea, Trueb Lionel, Eicher Manuela, Coukos George, 2018..
 
L’immunothérapie cellulaire adoptive arrive en Suisse : de nouveaux ou-TIL-s pour combattre le cancer. Onkologiepflege, Nr. 1-2018 (2018).
Colomer-Lahiguera Sara, Debarge Patricia, Serena Andrea, Trueb Lionel, Eicher Manuela, George Coukos, 2018..
MEF2C-dysregulated pediatric T-cell acute lymphoblastic leukemia is associated with CDKN1B deletions and a poor response to glucocorticoid therapy.
Colomer-Lahiguera S., Pisecker M., König M., Nebral K., Pickl W.F., Kauer M.O., Haas O.A., Ullmann R., Attarbaschi A., Dworzak M.N. et al., 2017/12. Leukemia & lymphoma, 58 (12) pp. 2895-2904. Peer-reviewed.
Complexity of NOTCH1 juxtamembrane insertion mutations in T-cell acute lymphoblastic leukemia
Colomer-Lahiguera Sara, Strehl Sabine, 2016/05/03. Leukemia & Lymphoma, 57 (5) pp. 1219-1222.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University